Lionsgate shares barely moved, down 0.3% to $12.99 at the latest close. The latest filing offers a more dramatic picture: revenue jumped 47.7% in the three months ended June 30, operating income turned positive, and operating cash flow swung to $54.1 million from negative $31.0 million.
The filing also shows a significant change in the expense lines, where share-based compensation climbed to $41.1 million from $1.7 million a year earlier. Diluted shares also rose to 291.6 million from 272.3 million, so the improved operating result came with higher share-based compensation expense attached.
Lionsgate explained the compensation increase as a valuation change in performance-based awards, rather than as a broad operating-cost trend:
"The increase in share-based compensation expense included in general and administrative expenses in the three months ended June 30, 2026, as compared to the three months ended June 30, 2025, was primarily due to higher fair values in the current fiscal period associated with performance-based stock option and other equity awards that are revalued at each reporting period until the stock option or equity award vests and the applicable performance goals are achieved."
10-Q, August 6, 2026
In plain English, the loss narrowed sharply, to $28.8 million from $108.9 million, but the income statement still carries a much bigger award-related expense than it did in the comparable period. The operating margin improved to 3.3% from negative 2.0%, while net margin remained negative.
The revenue surge also had a specific source. Lionsgate said international revenue increased $89.4 million, almost entirely because of the theatrical release of Michael.
"International revenue increased $89.4 million in the three months ended June 30, 2026, as compared to the three months ended June 30, 2025, primarily due to higher revenue generated from Lionsgate Original Releases of $88.8 million, driven by the theatrical slate title release of Michael in the current quarter ."
10-Q, August 6, 2026
That receipt ties much of the international increase to a single theatrical title, rather than establishing a steady sales run rate. The company's full-year revenue was $2.6 billion in the year ended March 31, 2026, up 1.8%, with a 3.7% operating margin. This three-month burst is considerably faster than the annual pattern.
Cash generation improved alongside the income statement. Cash rose to $425.8 million from $186.1 million, while accounts receivable fell 20.2% to $665.9 million. Management attributed the operating-cash increase to higher cash generated before working-capital changes, proceeds from receivables, and increases in participations and residuals, partly offset by greater investment in film and television programs.
Debt still matters to the arithmetic. Interest expense fell $11.8 million to $56.9 million, primarily because average rates on variable-rate corporate debt and film-related obligations were lower. That was a financing factor in the period rather than a new title in the library.
The company's annual record supplies the wider frame: operating margin moved from negative territory in fiscal 2024 and 2025 to positive 3.7% in fiscal 2026, while diluted shares rose 14.7% in that latest annual period. The latest three months therefore combine three moving parts: a release-driven revenue jump, better cash conversion, and more equity-linked compensation.
Lionsgate's next quarterly report will put a number on whether the $41.1 million stock-compensation expense recedes and whether operating cash flow stays positive. For now, the figures show more cash, less loss, and a larger stock-compensation expense.
Lionsgate’s latest filing: more cash, a smaller loss, and a much larger stock-compensation line.